PT  - JOURNAL ARTICLE
AU  - Mosley, Mary
ED  - Quyyumi, Arshed A.
TI  - PreSERVE-AMI: CD34+ Cells Improve Cardiac Function, Reduce Events after STEMI
DP  - 2014  01
TA  - MD Conference Express
PG  - 24--25
VI  - 14
IP  - 52
4099  - http://mdc.sagepub.com/content/14/52/24.short
4100  - http://mdc.sagepub.com/content/14/52/24.full
AB  - The intracoronary (IC) infusion of bone marrow mononuclear cells after an STEMI improved cardiac function, including left ventricular ejection fraction, infarct size, and end-systolic volume, and major adverse cardiac events. This article discusses the NBS10 (Also Known as AMR-001) Versus Placebo Post ST Segment Elevation Myocardial Infarction trial [PreSERVE-AMI; NCT01495364], which looked at IC autologous CD34+ cell therapy for STEMI patients.